Phase 2 Trial of Tivozanib and Nivolumab for Kidney Cancer
Phase 2
48
about 4.8 years
18+
5 sites in MA, MI, TX
What this study is about
This trial is testing if giving tivozanib with nivolumab can help control advanced kidney cancer. The treatment involves taking both medications.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Nivolumab
- 2.Take Tivozanib
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
nivolumab (Immune checkpoint inhibitor; blocks PD-1 receptor on T cells), tivozanib
infusion, oral (Oral Capsule)
Primary: Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0
Oncology